Pieris Pharmaceuticals (PIRS) Financials

$13.26

$-2.87 (-17.79%)

As on 13-Dec-2024 16:03EDT

Market cap

$21 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	1.35	42.81	25.90	31.42	29.32	46.28
Cost of Revenue	5.18	41.80	2.78	2.37	46.53	55.00
Gross Profit	-3.82	1.01	23.12	29.05	-17.21	-8.72
Operating Expenses	19.48	72.57	61.20	79.56	63.24	73.44
Operating Profit (EBIT)	-18.10	-29.76	-43.47	-51.83	-33.92	-27.16
Other Income	--	--	--	2.40	-3.66	-0.03
Profit before Tax	-15.95	-24.54	-33.28	-45.74	-37.07	-25.47
Provision for Tax	-0.77	13.91	-2.02	-2.37	0.16	-1.71
Profit after Tax (Net Income)	-15.95	-24.54	-31.25	-43.37	-37.23	-23.76
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-45.74	-37.23	-28.30

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	16.27	26.76	27.93	50.76	31.03	51.35
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	30.98	52.24	51.84	62.74
Current Liabilities	4.25	11.92	36.58	50.56	22.15	27.00
Total Liabilities	24.78	38.68	95.49	153.56	105.01	141.10

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	--	--	22.07	25.94	29.29	26.08
Current Assets	20.52	38.68	73.42	127.63	75.72	115.01
Total Assets	24.78	38.68	95.49	153.56	105.01	141.10
Total Debt*	--	--	13.10	13.84	16.96	16.22
Net Current Assets	16.27	--	36.84	77.06	53.58	88.01

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-53.82	-59.93	-7.66	-45.90	-52.47
Cash Flow from Investing Activities	--	--	--	-0.95	39.21	9.84
Cash from Financing Activities	--	19.80	7.21	59.13	10.12	32.17
Net Cash Inflow / Outflow	--	--	--	50.52	3.43	-10.46

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-72.41	-59.18	-77.04	-64.44	-44.19
ROE (%)	-83.45	-89.76	-79.44	-106.05	-90.39	-52.04
ROA (%)	-28.23	-36.58	-25.10	-33.54	-30.26	-16.82
EBIT Margin (%)	-1,156.14	-57.33	-128.47	-145.58	-115.05	-58.68
Net Margin (%)	-1,179.96	-57.33	-120.66	-128.22	-145.05	-51.36
Cash Profit Margin (%)	0.04	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-97.15	0.65	-0.18	0.07	-0.37	0.59
EBIT Growth (%)	-1,233.70	26.25	27.24	-35.57	-24.23	11.92
Net Profit Growth (%)	41.27	21.47	27.93	-16.48	-56.72	11.21
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.10	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.47	1.16	1.51	2.40	1.69	3.37
Close Price ($)	16.58	0.18	1.04	3.78	2.50	3.62
High Price ($)	18.68	1.97	4.08	6.15	4.30	6.04
Low Price ($)	0.14	0.14	0.85	1.70	1.60	2.44
Market Cap ($ Cr)	21.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	--	0.47	0.27	0.55	0.32
Short term debt to equity ratio	--	--	0.03	0.02	0.03	0.01
Current Ratio	4.82	3.24	2.01	2.52	3.42	4.26
Quick Ratio	4.82	2.90	--	--	3.42	--
Interest Coverage	-2.43	--	-3.26	-7.51	-10.73	-16.09

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	65.01	1.34	22.43	10.54	5.82	14.67
Asset Turnover	0.02	0.64	0.21	0.24	0.24	0.33
Receivable days	--	27.23	64.32	29.17	52.89	37.44
Inventory Days	--	35.71	--	0.00	0.00	0.00
Payable days	--	32.88	838.43	801.76	46.47	44.51
Cash Conversion Cycle	--	30.06	--	-772.59	6.42	-7.07

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.